We have identified a trans-dominant mutant form of the herpes simplex virus (HSV) DNA-binding protein ICP8 which inhibits viral replication. When expressed by the V2.6 cell line, the mutant gene product inhibited wild-type HSV production by 50-to 150-fold when the multiplicity of infection was less than 5. Production of HSV types 1 and 2 but not production of pseudorabies virus was inhibited in V2.6 cells. The inhibitory effect was not due solely to the high levels of expression, because the levels of expression were comparable to those in the permissive wild-type ICP8-expressing S-2 cell line. Experiments designed to define the block in viral production in V2.6 cells demonstrated (i) that viral a and I8 gene expression was comparable in the different cell lines, (ii) that viral DNA replication proceeded but was reduced to approximately 20% of the control cell level, and (iii) that late gene expression was similar to that in cells in which viral DNA replication was completely blocked. Genetic experiments indicated that the mutant gene product inhibits normal functions of ICP8. Thus, ICP8 may play distinct roles in replication of viral DNA and in stimulation of late gene expression. The dual roles of ICP8 in these two processes could provide a mechanism for controlling the transition from viral DNA synthesis to late gene expression during the viral growth cycle.
The major DNA-binding protein of herpes simplex virus (HSV), ICP8, is expressed as a p or delayed early gene product during productive infection. ICP8 is one of the seven virus-encoded proteins that are required for the replication of the HSV type 1 (HSV-1) genome (2, 4, 31, 44, 45) . The functions and activities performed by ICP8 have not been completely established. Some known properties of ICP8 include (i) the ability to localize to the cell nucleus independent of other viral proteins, (ii) the ability to bind DNA nonspecifically in vitro and in vivo, (iii) the ability to down-regulate the expression of ICP4 under certain conditions (12) , and (iv) the ability to promote assembly of DNA replication structures in the infected cell nucleus.
To study the functional domains of ICP8, we have constructed a variety of ICP8 gene mutations (9a, 10) . Phenotypic analysis of ICP8 gene mutants indicated that several regions of ICP8 are required for its nuclear localization (9b) . However, analysis of ICP8-pyruvate kinase fusion proteins showed that the carboxyl-terminal 28 residues of ICP8 comprise the only portion of ICP8 that can function alone as a nuclear localization signal.
ICP8 binds to single-stranded DNA (ssDNA) or doublestranded DNA in vitro (1, 26, 34, 39) , with at least a fivefold preference for ssDNA (28, 40) , and can be isolated in DNA-protein complexes from infected cells (27, 29) . The ICP8 sequences required for ssDNA binding have been mapped between residues 564 and 849, on the basis of the studies of a variety of ICP8 mutant viruses, of in vitro transcription-translation products of ICP8, and of partial protease digestion of purified ICP8 (10, 30, 43) .
The intranuclear location of ICP8 is determined, at least in part, by the status of viral DNA replication (5, 35) . In infected cells, before viral DNA synthesis ICP8 localizes to nuclear framework-associated structures called prereplicative sites (5, 35, 36) . As viral DNA replication occurs, ICP8 * Corresponding author.
migrates to replication compartments (5, 35) , where it is bound to progeny and replicating viral DNA (27, 29) . Viruses expressing an altered ICP8 molecule fail to assemble prereplicative sites. Therefore, ICP8 is required for the assembly of prereplicative sites (5) .
To further study the functional domains of ICP8, we have introduced various mutated ICP8 gene sequences into the viral genome (9a, 10) . However, we were unable to introduce certain mutations from ICP8 gene plasmids into the viral genome by recombination. One of these mutants has a small deletion between the sequences encoding the DNAbinding region and the nuclear localization signal of ICP8. This report describes that this mutant ICP8 protein exhibits a trans-dominant phenotype and can significantly inhibit the production of wild-type (wt) HSV-1. Analysis of this mutant phenotype suggests that wt ICP8 plays a role in the stimulation of late gene expression.
MATERIALS AND METHODS
Plasmids. The plasmid pSV8 and the nucleotide numbering system for the ICP8 gene were described previously (9, 20) . The plasmid pSV8 was constructed by inserting the ICP8 coding sequences (map units 0.374 to 0.409) downstream of the simian virus 40 early promoter in plasrrlid RL18:PK12 (24) . The plasmid pSV8.3 was derived from pSV8 by deleting the polylinker region and the SacI-BglII fragment of the pyruvate kinase gene. The plasmid pSVdlO5 was constructed by deletion of a BgllI fragment of pSV8.3 after the conversion of PvuII (nucleotide 3853) and NaeI (nucleotide 4111) sites to BgllI sites. Thus, pSVdlO5 lacks codons 1083 to 1168 of the ICP8 coding sequence but encodes four additional amino acids, Gly-Arg-Ser-Ser, in the BglII linker sequence. The plasmid pSG28 was provided by M. Levine (University of Michigan).
Cells and viruses. Vero cells were grown and maintained as described previously (25) . The growth medium for the neomycin-resistant cell lines S-2 (10) and V2.6 (see below) included 200 ,g of the antibiotic G418 per ml during the first passage of the cells after thawing or 500 ,ug of G418 per ml of medium every five passages.
The HSV-1 wt strain KOS1.1 was propagated and assayed as described previously (25, 27) . The mutant viruses d301 and nlO were grown and propagated in the ICP8-expressing S-2 cell line (10) . Pseudorabies virus (PRV) was provided by E. Sinn and R. Roeder (Rockefeller University).
For infections at a multiplicity of infection (MOI) of 2 PFU per cell for biochemical analysis, cell numbers were determined by cell counts of a culture flask of each cell line being used prior to the infection.
Isolation of d105 ICP8-expressing cell line. Vero cells were transformed with the plasmids pSVdlO5 and pSVneo ( Fig. 1 ) (42) as described previously (6, 10) . After growth in medium containing the antibiotic G418 (a neomycin analog), drugresistant colonies were isolated, grown into cultures, and screened by indirect immunofluorescence (5) using the lOE-3 anti-ICP8 monoclonal antibody (38) for the ability to express the mutant form of ICP8 upon nlO infection. The lOE-3 antibody recognizes diO5 ICP8 but not nlO ICP8 (9b) .
ssDNA cellulose chromatography. ssDNA cellulose chromatography of infected cell extracts was performed as described previously (10, 26) .
Analysis of viral proteins and viral DNA replication. Cell monolayer cultures were infected with KOS1.1 or d301 virus and then labeled with [35S]methionine and harvested as indicated below. Sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) of infected cell lysates was performed as described previously (25) . After electrophoresis, the gels were fixed, dried, and exposed to Kodak SB5 film, or the proteins were transferred by electrophoresis to nitrocellulose filters for Western immunoblot analysis. Immune complexes were detected on blots by a procedure involving a color reaction for alkaline phosphatase activity conducted as specified by the manufacturer (Promega Biotec, Madison, Wis.). The rabbit polyclonal serum PP5 (46) and the mouse monoclonal antibody lOE-3 (38) were used to detect HSV-1 DNA polymerase and ICP8, respectively.
Analysis of viral DNA amplification during the course of infection was performed as described previously (37) . The probes used were the plasmids pBR3441 (30) and pSG28 (13) . To quantify the data, the slots were cut out and radioactivity was measured by liquid scintillation counting.
Northern (RNA) blot analysis. Total cytoplasmic RNA for Northern blots was isolated and analyzed as described previously (37) . The plasmid used for the probe was pEcoRIBamHI-I-I (gC gene probe [8] (10) and that the C-terminal 28 residues of ICP8 can function as a nuclear localization signal (9b). Mutant dlOl ICP8 which is missing residues 17 to 563 localizes to the nucleus and binds to ssDNA but fails to promote viral DNA replication (10) . This indicates that the N-terminal half of ICP8 has a nuclear function other than DNA binding. The d105 mutant ICP8 has a deletion of residues 1082 to 1169 and exhibits a trans-dominant negative phenotype.
plasmid with 1 ,ug of infectious HSV-1 DNA into Vero cells; we observed that plaque numbers were dramatically decreased compared with those obtained when the wt ICP8 plasmid was cotransfected (Table 1) . Even when the molar ratio of the amounts of ICP8 gene sequences in diO5 plasmid to those in the infectious viral genome was only 2:1 (0.1 ,ug of dlO5 plasmid), significant inhibition of plaque formation was observed. Thus, the diO5 mutant showed a transdominant phenotype. In contrast, many other ICP8 mutants did not cause an inhibition of viral growth (data not shown).
The diO5 gene product was able to localize into the nucleus when it was expressed in Vero cells transfected with the pSVdlO5 plasmid (Fig. 2) . To study the phenotype of the diO5 gene product in more detail, we isolated a cell line named V2.6 which expressed dlO5 ICP8 upon HSV infection. The V2.6 cell line was a poor host for wt virus growth, despite the presence of wt ICP8 expressed from the viral genome. The plating efficiency of wt virus on V2.6 cells was 100-to 1,000-fold lower than that on Vero cells or on the wt ICP8-expressing S-2 cell line, and the size of the plaques was extremely small (data not shown). Single-cycle growth experiments showed that the yield of wt virus on the V2.6 cell line was 50-to 150-fold lower than that on Vero cells or on the wt ICP8-expressing S-2 cell line when the MOI was less than 5 (Table 2) . At an MOI of 0.1, the V2.6 cell line exhibited a yield of HSV-1 KOS1.1 reduced approximately 150-fold from that on Vero cells or on the wt ICP8-expressing S-2 cell line. The inhibition of growth on V2.6 cells was overcome at an MOI of 10. Thus, although the diO5 gene product could inhibit viral replication in the presence of wt ICP8 at low MOIs, the trans-dominant effect appeared to be due to competitive inhibition because the inhibition was decreased at a high MOI. Because significant inhibition was obtained at an MOI of 2.5 and most cells were infected, we chose an MOI of 2 to 2.5 PFU per cell for the biochemical studies described below.
To examine the specificity of resistance of the V2.6 cell line to HSV-1, we also tested the ability of the V2.6 cell line to restrict the growth of HSV-2 and of a closely related herpesvirus, PRV. An inhibitory effect of similar magnitude was observed for HSV-2 on the V2.6 cell line (data not shown). However, no decrease of virus yields was observed when PRV was plated on the V2.6 cell line ( Table 3 ). The induction of the mutant form of ICP8 in the V2.6 cell line by PRV was evidenced by Western blot analysis by using an antibody specific for ICP8 (data not shown). These results indicated that the inhibitory effect of mutant dlO5 was HSV specific.
To determine whether this inhibitory effect was exerted on ICP8, the mutant diO5 plasmid was cotransfected with increasing amounts of wt ICP8 plasmid. When this was done, the inhibition of the production of wt virus was a Vero cells, the wt ICP8-expressing S-2 cell line, and the V2.6 cell line expressing d105 ICP8 were infected with KOS wt virus at the indicated MOI and were incubated at 37°C. Cells were harvested 24 h after infection, and titers of the progeny viruses were determined on Vero cells. b Numbers in parentheses represent the fold greater yield on these cells relative to the yield on V2.6 cells.
partially relieved (Table 4 ). These results demonstrated that the inhibitory effect caused by the d105 gene product was a trans-dominant effect mediated on wt ICP8. The mutant d105 ICP8 binds to ssDNA. For many DNAbinding proteins, such as yeast GCN4 (22), trans-dominant mutant forms retain their DNA-binding ability but lose transactivation activity or their ability to interact with certain other proteins (reviewed in reference 18). Therefore, to determine whether the inhibitory gene product retained the ability to bind DNA, we infected V2.6 cells with a DNAbinding-negative ICP8 mutant d301 (10) . Extract from infected cells was passed over a ssDNA cellulose column, and ICP8 was eluted stepwise with buffer containing increasing salt concentrations. Polypeptides in the various fractions were analyzed by PAGE (data not shown) or Western blotting (Fig. 3) . In V2.6 cells infected with d301, a 120-kDa form of ICP8 was detected (Fig. 3, lanes 12 and 13) , in agreement with the predicted size of the diO5 gene product (9) . Mutant d301 ICP8 bound poorly to ssDNA cellulose (Fig. 3, lanes 12 through 15) and was found in the flowthrough fractions (lanes 7 and 8). In contrast, d105 ICP8 bound to ssDNA (Fig. 3, lanes 12 through 15) , and the majority of it was eluted with 0.5 M NaCl (lane 13). In other comparisons, dlO5 ICP8 bound to ssDNA with an efficiency similar to that of wt ICP8 (data not shown).
Partial inhibition of viral DNA replication in V2.6 cells. To determine whether the decreased viral yield in the V2.6 cell line was due to a block in viral DNA synthesis, we examined viral DNA replication (Fig. 4) . The d301 mutant virus, which contains a large deletion in the ICP8 gene and is unable to replicate its DNA (10), was included in the experiment as a negative control. Total DNA was isolated from mock-or wt virus-infected Vero cells, from the wt ICP8-expressing S-2 We also examined the amounts of ICP8 expression in the different cell types. Western blots (Fig. SB) revealed that the levels of wt ICP8 expression were equivalent in Vero (Fig.  5B, lanes 1 and 2) and V2.6 cells (Fig. 5B, lanes 5 and 6 ). This blot also shows that the amount of diOS ICP8 expressed in V2.6 cells (Fig. SB, lanes 5 and 6) was only slightly greater than the amount of wt ICP8 expressed in the permissive S-2 cells (Fig. SB, lanes 3 and 4) . Other Western blots demonstrated no apparent reduction of ICP4 expression. These results demonstrated that the major part of the inhibition of the growth of wt HSV-1 in the V2.6 cell line was not due to the inhibition of ot or ,3 gene expression.
To further examine viral gene expression in V2.6 cells, we infected Vero cells, wt ICP8-expressing S-2 cells, and V2.6 cells with wt HSV-1 in the absence or presence of sodium phosphonoacetate (PAA), a specific inhibitor of HSV-1 DNA synthesis, and we pulse-labeled the cells with [35S]methionine at 3, 6, or 12 h postinfection. The labeled proteins were separated by SDS-PAGE and visualized by autoradiography (Fig. 6) . The mutant form of ICP8 expressed from V2.6 cells, like wt ICP8 expressed from S-2 cells, was not constitutively expressed but was induced upon virus infection. The patterns of viral protein synthesis at 3 or 6 h postinfection were similar in the 3 different cell lines, except that significant amounts of the mutant form of ICP8 expressed from the V2.6 cell line and of wt ICP8 expressed from the S-2 cell line were observed. The amount of the mutant form of ICP8 produced by the V2.6 cell line was greater than that of wt ICP8 in Vero cells (Fig. 6 , lanes 21 and 19) but was comparable to that produced by the wt ICP8-expressing S-2 cell line (Fig. 6, lanes 21 and 20) at 12 h postinfection. Although slightly greater amounts of d105 ICP8 than of S-2 ICP8 were expressed at 6 h postinfection in this experiment (Fig. SB and 6, lanes 14 and 15) , this was not observed in other experiments (data not shown). Because S-2 cells were as permissive for HSV as Vero cells (Table 2) late gene expression. To determine whether this was the case, we used various concentrations of PAA to attempt to reduce viral DNA synthesis in Vero cells or in the wt ICP8-expressing S-2 cell line to levels similar to that of the V2.6 cell line in the absence of PAA. Thus, if the level of DNA synthesis was the sole determinant of the levels of late gene expression, late gene expression would then be similar in the different cell lines. Cells were infected with wt virus and harvested at 16 h postinfection for analysis of viral DNA and protein synthesis (Fig. 7) . With increasing concentrations of PAA, decreasing amounts of viral DNA amplification and late gene expression were observed in Vero cells or in S-2 cells. At a PAA concentration of 400 ,g per ml, viral DNA synthesis was completely inhibited, and no -y2 viral polypeptide synthesis (e.g., ICP15) was observed. At PAA concentrations between 80 and 160 ,ug per ml, the amounts of viral DNA synthesized in Vero cells or in S-2 cells were similar to that synthesized in V2.6 cells infected without PAA. However, under these conditions, synthesis of viral polypeptides of -yl (ICP5 and ICP25) and -y2 (ICP15) classes in the V2.6 cells was markedly reduced compared with that in Vero cells or in S-2 cells. Quantitation of ICP5 synthesis by densitometry indicated that in V2.6 cells the rate of synthesis of ICP5 was approximately eightfold lower than in Vero cells or S-2 cells. Therefore, we conclude that the lack of late gene expression in the inhibitory V2.6 cell line was not due entirely to the decreased amount of viral DNA synthesis.
To further define the level at which late gene expression was decreased, we performed Northern blot analysis to measure the steady-state level of y2 gC mRNA (Fig. 8 ) in different cells. Infection of Vero cells or V2.6 cells was carried out in the absence or in the presence of 100 ,ug of PAA per ml. Total cytoplasmic RNA was isolated from infected cells at 16 h postinfection. Equal amounts of total cellular RNA were probed on a Northern blot with a 32P-labeled DNA fragment for the gC gene. No gC mRNA was detected in mock-infected V2.6 cells (Fig. 8) . As expected, partial inhibition of viral DNA synthesis by PAA reduced the amounts of gC mRNA in Vero cells or in S-2 cells. At a PAA concentration of 100 ,g per ml, the level of gC mRNA in V2.6 cells was at least sixfold less than in the other cells. Therefore, the block in late gene expression in V2.6 cells was due, at least in part, to a decrease in mRNA accumulation.
simply due to overexpression of the mutant form of ICP8. In addition, the amount of wt ICP8 produced by wt virus infection on the V2.6 cell line was only slightly reduced compared with that on Vero cells (Fig. 6, lanes 19 and 21) . This result was consistent with those in Fig. 5 , suggesting that the inhibition of wt virus growth on the V2.6 cell line was not a consequence of the mutant form of ICP8 attenuating the expression of a. and L genes.
In contrast, the synthesis of viral polypeptides of -yl (ICP5 and ICP25) and y2 (ICP1-2 and ICP15) classes was markedly reduced in V2.6 cells (Fig. 6, lane 18 ) compared with that in Vero cells (lane 16) or the wt ICP8-expressing S-2 cell line (lane 17). In fact, the pattern of viral polypeptide synthesis at 12 h postinfection was almost identical to that observed in the absence of viral DNA synthesis (Fig. 6, Two HSV-1 trans-dominant mutant gene products have been reported (7, 41) . It was hypothesized that these mutant gene products interfered with wt viral functions either by formation of nonfunctional dimers (41) or by tying up cell factors in inactive complexes (7) . The reduction in titer of wt virus stock observed on these different inhibitory cell lines varied from mutant to mutant, but in most cases it was in the range of 10-to 40- binding protein than to the ElA transactivator protein, suggesting that the DNA-binding protein plays a central role in activation of the late promoter. Several T4 bacteriophage gene 32 mutants synthesized high levels of viral DNA (30 to 55% of wt virus level) but were defective for the synthesis of late gene 23 protein, the major structural protein of the T4 capsid (11) . The amounts of mRNA were also greatly reduced for at least 3 late genes in these gene 32 mutants. These results demonstrated a direct requirement for gene 32 protein in the activation of late gene expression. The E. coli SSB protein activates promoters transcribed by the bacteriophage N4 virion RNA polymerase and is also required to initiate transcription from specific promoter sites on doublestranded DNA (15) . In addition, the DNA replication protein gp45 of bacteriophage T4 has also been demonstrated to be directly required for late gene expression (16) . These three T4-encoded DNA polymerase accessory proteins stimulate the opening of T4 late promoters, and the activation of late promoters in vivo by these three proteins is effected by moving replication forks acting as mobile enhancers (16, 17 
